#USA #Los Angeles #Schall Law Firm #Securities Fraud #INOVIO Pharmaceuticals

Investors Encouraged to Join Inovio Pharmaceuticals Lawsuit

In a significant legal development, the Schall Law Firm is reaching out to investors affected by the recent downturn in Inovio Pharmaceuticals, Inc. (NASDAQ: INO). This national shareholder rights litigation firm is inviting those who purchased Inovio securities between October 10, 2023, and December 26, 2025, to participate in a class action lawsuit targeting alleged violations of the Securities Exchange Act of 1934.

Background of the Case

The lawsuit stems from claims that Inovio Pharmaceuticals made misleading statements regarding their products and business operations. Investors have suffered losses as a result of these alleged misrepresentations. The Schall Law Firm is reminding shareholders that they must act by April 7, 2026, to secure their representation and potentially recover losses incurred during the class period.

According to the complaint filed by the firm, Inovio was struggling with manufacturing issues related to its CELLECTRA device, which directly affected the company's ability to file for BLA (Biologics License Application) for their INO-3107 product by the expected timeframe. The lawsuit alleges that Inovio failed to provide sufficient evidence to support an FDA priority review or accelerate approval, leading to significant misinformation in the marketplace.

When the actual challenges facing Inovio became public knowledge, investors began to unearth the reality behind the company’s operational difficulties. The public statements from Inovio were thus described as false and misleading during the class period, as they did not align with the actual circumstances of the company’s performance.

A Call to Action for Investors

If you are among the investors who purchased Inovio securities within the specified timeframe and experienced losses, this lawsuit provides an opportunity to voice your grievances legally. The Schall Law Firm believes strongly in the rights of investors and aims to protect your interests through this class action. You can initiate the process by contacting them for a free consultation to discuss your situation.

Reach out to Brian Schall at their offices located at 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, or call directly at 310-301-3335. Those interested in learning more about the case can also visit the firm's website for additional information and support.

The Importance of Timely Action

It is crucial for potential class members to act promptly. While the class action is still pending certification, joining early can help ensure that you are properly represented. If you choose to remain inactive, you may lose the chance to be part of this lawsuit and possibly miss out on recovery for your losses.

Conclusion

As a leading advocate for investor rights, the Schall Law Firm remains committed to pursuing justice for those misled in the financial markets. Participation in this class action may not only serve as a vital step in holding Inovio accountable but could also potentially provide financial restitution for affected shareholders. Don’t hesitate – contact the Schall Law Firm today to reclaim your rights as an investor.